Trending tickers: Boeing, Sanofi, SAP, Nokia and Tata Consumer Products

In This Article:

Boeing (BA)

US planemaker Boeing is heading into a busy week, with investors watching developments closely around its costly labour strike, as well as its latest quarterly results.

More than 33,000 unionised workers, who have been on strike for more than a month, are set to vote on Wednesday whether they will accept Boeing's offer of a 35% pay rise over four years.

Boeing said last week that it was aiming to secure $35bn (£27bn) in funding to shore up its balance sheet, as the company continued to deal with the labour dispute with its largest union.

Just days before that, Boeing released its preliminary third-quarter results, with the planemaker saying it expected to report a GAAP loss per share of $9.97, with operating cash flow of -$1.3 billion.

Read more: FTSE 100 LIVE: London stocks rise as China rate cut supports miners

The company also said it would end production of its 767 tanker jet and push back the release of its upcoming 777X widebody jet.

In addition, new CEO Kelly Ortberg also announced the company would lay off 10% of its labour force, or around 17,000 employees.

On Sunday, the Wall Street Journal reported that Boeing was exploring the sale of assets to bolster its finances.

Investors will be looking for more detail on the company's financial situation when it releases its full third-quarter results on Wednesday.

Shares were up 3.4% in pre-market trading on Monday morning but are down nearly 41% year-to-date.

Sanofi (SAN.PA)

The French government has taken a small stake in Sanofi's consumer healthcare business Opella, following political backlash about the pharmaceutical company's deal with a US private equity firm.

Sanofi announced Monday that it had entered exclusive negotiations with American private equity company Clayton, Dublier & Rice to transfer a 50% controlling stake in Opella.

The company said Bpifrance, the French state-owned lender, was also expected to participate in the deal as a minority shareholder with stake of around 2%.

Read more: Pound, gold and oil prices in focus: commodity and currency check, 21 October

The planned sale of Opella to CD&R had caused some controversy over implications as to what it could mean for jobs in the France. Marc Ferracci, France's industry minister, reportedly said in an interview with France Inter radio last week that the option to block the deal was "absolutely on the table" if it didn't meet the government's terms.

In Monday's announcement, Sanofi CEO Paul Hudson appeared to try to allay concerns. He said: "We share the love and emotional attachment to Opella’s brands, hence our decision to remain vested in its future.